(NASDAQ: QTRX) Quanterix's forecast annual revenue growth rate of 6.42% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.02%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.06%.
Quanterix's revenue in 2026 is $148,150,000.On average, 5 Wall Street analysts forecast QTRX's revenue for 2026 to be $6,934,223,533, with the lowest QTRX revenue forecast at $6,639,857,317, and the highest QTRX revenue forecast at $7,183,960,033. On average, 5 Wall Street analysts forecast QTRX's revenue for 2027 to be $7,569,010,035, with the lowest QTRX revenue forecast at $7,174,939,133, and the highest QTRX revenue forecast at $7,846,758,804.
In 2028, QTRX is forecast to generate $8,533,296,786 in revenue, with the lowest revenue forecast at $8,156,318,115 and the highest revenue forecast at $8,869,918,798.